aTyr Pharma, Inc. (ATYR) — Capital Reinvestment Ratio
Latest as of March 2020:
0.08x
aTyr Pharma, Inc. (ATYR) has a Capital Reinvestment Ratio of 0.08x as of March 2020, meaning it reinvests 0% of its operating cash flow ($2.06 Million) in capital expenditures ($166.00K). See debt-free asset ratio of aTyr Pharma, Inc. to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
0.08x
Capex / Operating Cash Flow
Operating Cash Flow
$2.06 Million
USD
Capital Expenditures
$166.00K
USD
Data as of
Mar 2020
Most recent filing
Annual Capital Reinvestment Ratio for aTyr Pharma, Inc. (None–None)
Year-by-year Capital Reinvestment Ratio for aTyr Pharma, Inc. from None to None. For live market cap and broader valuation context, see market cap of aTyr Pharma, Inc..
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow